George Soros's TERN Position Overview
George Soros (via Soros Fund Management LLC) currently holds 321,905 shares of Terns Pharmaceuticals, Inc. (TERN) worth $16.97 M, representing 0.19% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, George Soros has initiated a new position in TERN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
George Soros's Terns Pharmaceuticals (TERN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Terns Pharmaceuticals (TERN) Trades by George Soros
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +321,905 | New Buy | 321,905 | $52.72 |
George Soros's Terns Pharmaceuticals Investment FAQs
George Soros first purchased Terns Pharmaceuticals, Inc. (TERN) in Q1 2026, acquiring 321,905 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
George Soros has held Terns Pharmaceuticals, Inc. (TERN) for 1 quarters since Q1 2026.
George Soros's largest addition to Terns Pharmaceuticals, Inc. (TERN) was in Q1 2026, adding 321,905 shares worth $16.97 M.
According to the latest 13F filing for Q1 2026, George Soros's firm, Soros Fund Management LLC, owns 321,905 shares of Terns Pharmaceuticals, Inc. (TERN), valued at approximately $16.97 M.
As of the Q1 2026 filing, Terns Pharmaceuticals, Inc. (TERN) represents approximately 0.19% of George Soros's publicly disclosed stock portfolio, making it one of their key holdings.
George Soros's peak holding in Terns Pharmaceuticals, Inc. (TERN) was 321,905 shares, as reported at the end of Q1 2026.